Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Positive and Placebo-Controlled Study to Evaluate the Effects of HSK3486 Administration on Cardiac Repolarization in Healthy Subjects

NCT06795204 is registered in ClinicalTrials.gov with Haisco-USA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06795204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Positive and Placebo-Controlled Study to Evaluate the Effects of HSK3486 Administration on Cardiac Repolarization in Healthy Subjects
Lead sponsor
Haisco-USA Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 9, 2024
Completion date
November 26, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia; adverse effect, cardiac arrhythmia